experimental group :Canagliflozin

2 trials

Sponsors

Tianjin Medical University Chu Hisen-I Memorial Hospital, The Affiliated Drum Tower Hospital of Nanjing University Medical School

Conditions

Newly diagnosed type 2 diabetesType 2 diabetes

Phase 4

Evaluation of the early renal protective effects of Canagliflozin in patients with newly diagnosed type 2 diabetes mellitus using Blood Oxygen Level-Dependent and Arterial Spin Labeling MRI

Active, not recruitingChiCTR2000037951

Tianjin Medical University Chu Hisen-I Memorial HospitalNewly diagnosed type 2 diabetes

Start: 2019-09-01Updated: 2020-11-16

Effect of canagliflozin on cardiac function in patients with type 2 diabetes mellitus and high cardiovascular risk

RecruitingChiCTR2100051190

The Affiliated Drum Tower Hospital of Nanjing University Medical SchoolType 2 diabetes

Start: 2021-10-08Updated: 2022-05-23

Related Papers

Sodium-dependent glucose transporter 2 inhibitor alleviates renal lipid deposition and improves renal oxygenation levels in newly diagnosed type 2 diabetes mellitus patients: a randomized controlled trial.

2023-12-074 citations